{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:46:24Z","timestamp":1791852384690,"version":"4.3.4"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.2169\/internalmedicine.4836-20","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T22:05:51Z","timestamp":1600466751000},"page":"367-372","source":"Crossref","is-referenced-by-count":16,"title":["Effectiveness of Levodopa in Patients with Multiple System Atrophy and Associated Clinicopathological Features"],"prefix":"10.2169","volume":"60","author":[{"given":"Chiho","family":"Ishida","sequence":"first","affiliation":[{"name":"Department of Neurology, National Hospital Organization Iou National Hospital, Hokuriku Brain and Neuromuscular Disease Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Iou National Hospital, Hokuriku Brain and Neuromuscular Disease Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kato-Motozaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Iou National Hospital, Hokuriku Brain and Neuromuscular Disease Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuro","family":"Tagami","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Iou National Hospital, Hokuriku Brain and Neuromuscular Disease Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyonobu","family":"Komai","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Iou National Hospital, Hokuriku Brain and Neuromuscular Disease Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Perez-Lloret S, Flabeau O, Fernagut P, et al. Current concepts in the treatment of multiple system atrophy. Mov Disord Clin Pract 2: 6-16, 2015.","DOI":"10.1002\/mdc3.12145"},{"key":"2","unstructured":"2. Low PA, Reich SG, Jankovic J, et al. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol 14: 710-719, 2015."},{"key":"3","unstructured":"3. Wenning GK, Geser F, Krismer F, et al.; European Multiple System Atrophy Study Group. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12: 264-274, 2013."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ito H, Kusaka H, Matsumoto S, Imai T. Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy. Neurology 47: 1291-1299, 1996.","DOI":"10.1212\/WNL.47.5.1291"},{"key":"5","unstructured":"5. Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar system in multiple system atrophy: clinicopathological correlations. 127: 2657-2671, 2004."},{"key":"6","unstructured":"6. Tison F, Wenning GK, Daniel SE, Quinn NP. Multiple system atrophy with Lewy bodies. Rev Neurol 151: 398-403, 1995 (in French, Abstract in English)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Trojanowski JQ, Revesz T. Neuropathology Working Group on MSA. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 33: 615-620, 2007.","DOI":"10.1111\/j.1365-2990.2007.00907.x"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 47: 1-9, 1996.","DOI":"10.1159\/000113224"},{"key":"9","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","volume":"44","author":"JJ Hauw","year":"1994","unstructured":"9. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski Syndrome (progressive supranuclear palsy). Neurology 44: 2015-2019, 1994.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Horimoto Y, Aiba I, Yasuda T, et al. Longitudinal MRI study of multiple system atrophy-when do the findings appear, and what is the course? J Neurol 249: 847-854, 2002.","DOI":"10.1007\/s00415-002-0734-0"},{"key":"11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"11. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71: 670-676, 2008.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"12","unstructured":"12. Watanabe H, Saito Y, Terao S, et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 125: 1070-1083, 2002."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tada M, Onodera O, Tada M, et al. Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy. Arch Neurol 64: 256-260, 2007.","DOI":"10.1001\/archneur.64.2.256"},{"key":"14","unstructured":"14. Glasmacher SA, Leigh PN, Saha A. Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 88: 402-411, 2017."},{"key":"15","unstructured":"15. Petrovic IN, Ling H, Asi Y, et al. Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 27: 1186-1900, 2012."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/3\/60_4836-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T05:42:37Z","timestamp":1612590157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/3\/60_4836-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4836-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}